And whoever made that bearish assessment is probably shorting the stock.

SOBR has been doing a painful (for the SH) reverse split once every two years or so. Two years will be up again this April, so I see another R/S this year. Not good.

Elias A Zerhouni Vice Chairman wouldn't be investing $511,779.00 at .93 if their wasn't the believe that the price would go higher.

Transaction Date Name Title Buy/Sell Number of Shares Average Share Price Total Transaction Details
1/5/2024 Elias A Zerhouni Vice Chairman Buy 550,300 $0.93 $511,779.00
1/5/2024 Richard C Pfenniger Jr Director Buy 25,000 $0.94 $23,500.00
1/5/2024 Steven D Rubin VP Buy 10,000 $0.87 $8,700.00
11/13/2023 Richard C Pfenniger Jr Director Buy 25,000 $1.30 $32,500.00
11/10/2023 Jane Ph D Hsiao Vice Chairman Buy 100,000 $1.27 $127,000.00
11/10/2023 Steven D Rubin VP Buy 10,000 $1.30 $13,000.00
11/9/2023 Phillip Md Et Al Frost CEO Buy 500,000 $1.28 $640,000.00

I was in Houston in 1984. Nice town. GLTU on your investments.

Reversion to the Mean. This will rebound. Oversold (undervalued) here. This is a great short term buy opportunity.

Are you really caring for 3 babies? I lived in TX when I had a job at Exxon downtown Houston. 20 years ago.

Hope you are right. I've gotten burned on biotechs during covid due to FDA corruption (and bad decisions on my part).

Did anyone figure out what caused that pop to $10? It's easy to say market manipulation, but has anyone specifically figured out what happened there?

The FDA never tested the current mRNA vaccine. They just tweaked it for the current variant with no clinical trials. Even though it has been proven that their vaccine causes heart attacks and other heart issues with the young. Very sloppy and unprofessional IMO. Yet they will raise the bar of standard off-the-charts for Revives drug. The FDA is corrupt and they are bought off by Big Pharm. Until Congress gets involved, it will be more of the same for decades to come. We might need a hard ass like Trump to fix this. For better or worse.

There was a R/S on 9/30/19 (1 for 50). I will wait for the aftermath to settle down after the next R/S before getting in here.

Yaa, very quiet. I was hoping for a decision by now.

Pegs,

IMO I think working through India is your best bet. I think we are years away in the USA before aviptadil is FDA approved for anything.

What is the ticker symbol for that EV battery stock? I'll put it on my watch list.

Take care, and I wish you the best. Keep fighting the fight!

Not sure I understand your point. $1.16 is $1.16. Good for some SH.

For me, now I have to swing trade this at a higher range. Buy at 1.10, take profits at s 1.16

I don't think so. I suspect we'll see another pull back. Profit taking.

The judge will make a decision on the merger with Spirit any day now. If the judge lets the merger go through, the shorts will have to quickly cover resulting in a squeeze.

From a technical analysis (TA) point of view, I see JBLU currently overvalued, hence a 'pull back' will occur (profit taking).

What the near-term future holds after that depends on the judges decision IMO. Which could be any day now. But thus far his hints have leaned in favor of JBLU. We'll see.

https://www.wsj.com/livecoverage/stock-market-today-dow-jones-12-07-2023/card/jetblue-stock-rises-after-airline-lifts-q4-outlook-8dv7J0NgMJ6alTrTfte4?siteid=yhoof2

Trial over JetBlue's Spirit merger ends with US judge mulling options
Tue, December 5, 2023
https://finance.yahoo.com/news/jetblue-trials-end-urges-judge-151836412.html?fr=sycsrp_catchall

Federal Judge Leans Towards Approval of JetBlues Acquisition of Spirit Airlines
December 6, 2023

On December 6, 2023, a significant development unfolded in the aviation industry as a federal judge leaned towards granting approval for JetBlue’s proposed acquisition of Spirit Airlines, valued at a staggering $3.8 billion. Despite the Justice Department’s efforts to impede the deal, the judge hinted that it could move forward under the condition that JetBlue divests additional assets to address potential antitrust concerns.

While the Justice Department argued vehemently that the merger would result in inflated prices and reduced flight options, the judge expressed reservations about obstructing a deal within an industry that is constantly evolving and facing unprecedented challenges in the post-COVID era. This dynamic environment presents both unique opportunities and hurdles that must be carefully considered.

The final verdict ultimately rests in the hands of the judge presiding over the non-jury trial in Boston, who holds the authority to shape the future of this pivotal acquisition.

B.S.

Upbeat forecast..... https://www.forbes.com/sites/greatspeculations/2023/11/27/whats-next-for-jetblue-stock-after-a-35-fall-this-year/?sh=44386eb02416

2 cents may be a good entry point for a short to intermediate term speculative play. One good, solid PR and this could be a quick 5-10 banger, even it the pop most likely would be short lived. Of course things could get worse, but downside risk at this point is rather small IMO. O/S size is still manageable, so there shouldn't be an R/S short-term. JMHO

I've been in TSOI for almost 2 years. As I've posted in the past, this is a "Long Term" multi-year investment. It's NOT for swing traders or day traders. The FDA coupled with bio-ech research takes a lot of time.

As I've also posted in the past, IMO the only major long-term risk with this is the risk of an R/S due to the grossly high O/S. However, Tim has gone on record stating that he will never do an R/S under his watch. However.... there are other strategies that he could do to fix the balance sheet, and they would not be good for the SH.

So bottom line: this is a long-term (multi-year) RISKY investment. That's why it's called a "Penny Stock". So one should never put all of their eggs in one basket. Diversify. Those that thought that they could get-rich-quick in TSOI made a Big Mistake. JMHO

It's just a matter of time until we see a monster pps spike on good news. I'm patient.

I think this will be at $10 by spring (April) 2024. This is a well run airline. They are just coping with a few things that are outside of their control. I view them as seasonal issues. Having said that, I don't like having $$ tied up for that long. Hopefully the outcome of the ongoing law suit will give the pps a spike (boost). Outcome should occur in December.

Whoever said that basically don't know what they are talking about, and they don't understand Risk Management. It's called 'correlation'. The goal is to spread the risks, and minimize correlation across sectors. In other words, purchasing two American airline stocks is not well diversified because they are in the same sector. So if the American airline industry as a whole gets hits with bad news, then most American airline stock prices get hurt together.

I'm afraid that even if you won the law suit, this company has no money to compensate the SH.

Yes, RLFTF is buried. Got that right.

Rick.. you can't be serious. Let's get real. This thing has sunk to 2 pennies. And it may soon go sub-penny. How can you pump and defend this CEO and their mission. They have failed the SH. Period. They virtually have no cash in the bank to finance their fat salaries and bonus checks. R/S is next on the agenda. Just watch. MF is the Shroom King. Which got him nowhere. I was long this stock once. Never lost anything because I saw the light and exited. But I did lose some $ on RLFTF. I'll man up to that.

These foreign biotech entities seeking EUA under the FDA umbrella has been a SCAM. They scammed us all. They never had a chance with the FDA which gives preference to BigPharm

IMO this is a 2x or 3x banger somewhere between now and spring 2024. JMHO

MF often looks like he is doped up on his own shrooms. Sorry. I couldn't help that.

It will be an R/S. That will regenerate the cash flow to keep financing the salaries and bonuses. It is what it is. Unfortunately this was simply an EUA dream, just like so many other tiny biotech during the COVID era. I got a burned a bit by the the same dream with RLFTF. They did the nasty R/S (1 for 400), which wiped the SH out. Ouch. Of course they sold the R/S with PRs that it was to get to the NASDAQ, which never happened. It's SOP in the pennyworld.

med.. next stop is the r/s. May not see it till spring/summer/fall 2024. All down from here I'm afraid.

This is a vey sad state of affairs. I do feel for the longs who got suckered into this by a CEO who literally cannot speak in a professional, fluent manner. This CEO is a joke.

I got lured in and scammed by RLFTF. That's a whole different story.

But these two foreign entities are very similar.

These foreign biotech CEO's (Canada and Switzerland). are both penny stock scams.

I only speak the truth. No pumps. No bashes. Have you even seen/listened to this CEO talk. He couldn't even run a dime store.

RVVTF is not Novartis. Let's get real here. The r/s will happen. Write that down and I stand by it.

That funding will not pay for the salaries and bonuses of mgmt. You know that. Hence, the r/s is inevitable.

I cannot count the number of times I've heard that excuse with penny stocks. Then when the r/s occurs, everyone is shocked. OMG... how did that happen!

I agree.

RVVTF will run out of money required to pay other bills before this study is complete. Hence, an r/s. They need to start generating revenues (and profits) to avoid an r/s. JMHO

med.. based on your excerpts, it looks like you got duped too!